This training will provide you with a sense of security in medical practice, which will help you grow personally and professionally”

The specialist plays a fundamental role in the approach to the oncological process, and his diagnostic and therapeutic orientation is key. But equally, there are components of the disease process that require special monitoring to avoid risks and facilitate the greatest possible wellbeing for the patient.

Cardiotoxicity is routinely present as one of the side effects of many of the treatments for the oncology patient. The management of the medication, as well as of other therapeutic options, is fundamental in the adjustment of the appropriate dosage for medical practice, and its undesired effects must be managed with the utmost rigor. Keeping up to date with advances in cardiotoxicity in oncology patients is a key factor for doctors in their daily clinical practice.

This program is designed to facilitate the specialist's updating process, so that he/she can include in the clinical practice of their patients all the innovations and the latest knowledge about oncological therapeutics and its complications.

Update your knowledge with the postgraduate diploma program in The The Comprehensive Management of Cardiotoxicity in the Oncologic Patient"

The postgraduate diploma contains the most complete and up to date scientific program on the market. The most important features of the program include:

• Development of case studies presented by experts in The Comprehensive Management of Cardiotoxicity in the Oncologic Patient. The graphic, schematic, and eminently practical contents with which they are created provide scientific and practical information on the disciplines that are essential for professional practice
• New developments in cardiotoxicity of oncologic etiology
• It contains practical exercises where the self-evaluation process can be carried out to improve learning
• With special emphasis on innovative methodologies in cardiotoxicity
• All of this will be complemented by theoretical lessons, questions to the expert, debate forums on controversial topics, and individual reflection assignments
• Content that is accessible from any fixed or portable device with an Internet connection

Update your knowledge with the postgraduate diploma program in The Comprehensive Management of Cardiotoxicity in the Oncologic Patient"

Its teaching staff includes professionals belonging to the field of cardiotoxicity in cancer patients, who bring to this training the experience of their work, in addition to recognized specialists belonging to prestigious reference societies and universities.

The multimedia content developed with the latest educational technology will provide the professional with situated and contextual learning, i.e., a simulated environment that will provide immersive training program to train in real situations.

The design of this program is based on Problem-Based Learning, by means of which the student must try to solve the different professional practice situations that arise throughout the course. For this, the student will be assisted by an innovative interactive video system developed by recognized experts in the field of cardiotoxicity in oncology patients, with extensive teaching experience.

Increase your decision-making confidence by updating your knowledge through this postgraduate diploma"

Make the most of this opportunity to learn about the latest advances in the approach and follow-up of cardiotoxicity in cancer patients, and improve the care of your patients"

The postgraduate diploma in The Comprehensive Management of Cardiotoxicity in the Oncologic Patient is oriented to facilitate the updating of the physician responsible for the treatment and follow-up of the oncologic patient, in a simple and practical way, through the latest educational technology.

This postgraduate diploma is designed for you to update your knowledge in The Comprehensive Management of Cardiotoxicity in the Oncologic Patient, using the latest educational technology, to contribute with quality and safety to decision making"

General Objective

• To update the knowledge of the specialist Cardiologist, Oncologist and Hematologist in the field of Cardio-Oncology
• Promote work strategies based on a comprehensive approach to the patient as a standard model for achieving excellent care
• Encourage the acquisition of technical skills and abilities, through a powerful audio-visual system, and the possibility of development through online simulation workshops and/or specific training
• To encourage professional stimulation through continuous education and research

Specific Objectives

• Be able to perform a comprehensive risk assessment of patients undergoing oncologic treatment
• Describe the monitoring required by patients during treatment with cardiotoxic therapies
• Identify biomarkers as a method used to detect cardiotoxicity early, especially troponins and natriuretic peptides
• Know the oncological treatments associated with the appearance of cerebral vascular disease
• Learn the relationship of some oncological treatments with the development of pulmonary hypertension
• Define strategies to identify and control risk factors to limit the development of cardiotoxicity related to oncologic drugs
• Know the measures capable of limiting cardiac toxicity due to anthracyclines
• Know the measures capable of limiting cardiac toxicity due to trastuzumab-type monoclonal antibodies
• Know the measures capable of limiting cardiac toxicity related to cellular kinase inhibitors
• Learn strategies to limit the risk of toxicity related to radiotherapy
• Analyze the role of beta-blockers in cardioprotection
• Analyze the role of angiotensin receptor inhibitors and antagonists in cardioprotection
• Identify other pharmacological treatments with a possible cardioprotective effect
• Become familiar with the monitoring required for patients with cardiac toxicity or at high risk of developing it
• Explain the long-term follow-up of the patient who has received thoracic radiotherapy
• Understand the occurrence and determine the clinical management of patients with established oncologic disease who present with an acute ischemic event
• Understand the onset and determine the clinical management of the pediatric patient requiring potentially cardiotoxic oncologic treatment
• Understand the onset and determine the clinical management of the geriatric patient requiring oncologic treatment
• Get up to date on anticoagulant and antiplatelet therapy in oncology patients
• Broaden knowledge in relation to oncology patients who exhibit arrhythmias and require implantable devices (pacemakers, defibrillators)
• Recognize the importance of research in the context of cardiotoxicity
• Become familiar with current basic lines of research and future perspectives
• Become familiar with current clinical lines of research and future perspectives

Make the most of the opportunity and take the step to get up to date on the latest developments in The Comprehensive Management of Cardiotoxicity in the Oncologic Patient"